SIGN-UP NOW! SIGN-UP NOW! Click to become a The VoiceAmerica Talk Member for Free!
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
Navigating the Cancer Maze

Navigating the Cancer Maze

Archives Available

November 07th 2014:An Answer to Cancer - How Your Immune Body-Clock can assist Complete Remission

Could timing of cancer treatments be the missing link in delivery of cancer therapies? Sounds too simple to be true? Two cancer researchers Martin Ashdown & Brendon Coventry are "immunological explorers" who not only unearthed a buried "treasure"; but they have also created a map for other innovative cancer "explorers" to follow. The "treasure" is a cancer drug used for more than 20 years that is now providing oncologists with new information about how to best help patients achieve complete remission. The drug called interleukin-2, is providing cancer researchers with something akin to how the

Read more
Share Email SHARE

Tune in

Archives Available on VoiceAmerica Health and Wellness Channel

Featured Guest

Guest Image

Martin Ashdown

Martin Ashdown is a Melbourne based scientist, Research Fellow at the Faculty of Medicine University of Melbourne. Martin has made the observation that the immune response in the late stage cancer patient is oscillating repeatedly over an approximate seven day period or cycle. This observation may have profound implications for the timed delivery of various therapies, which via immune modulation may increase complete response rates, reduce toxicity and substantially reduce the cost of treatment. Martin has co-designed trials at international institutions and presented at international conferences advocating monitoring patients prior to treatment and accurately timing therapy as pulses.This
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
Facebook Twitter Linkedin Social Media